KYMR
Price
$58.05
Change
+$0.15 (+0.26%)
Updated
Oct 6, 11:22 AM (EDT)
Capitalization
4.14B
24 days until earnings call
REPL
Price
$4.60
Change
-$0.13 (-2.75%)
Updated
Oct 6, 02:25 PM (EDT)
Capitalization
369.2M
43 days until earnings call
Interact to see
Advertisement

KYMR vs REPL

Header iconKYMR vs REPL Comparison
Open Charts KYMR vs REPLBanner chart's image
Kymera Therapeutics
Price$58.05
Change+$0.15 (+0.26%)
Volume$600
Capitalization4.14B
Replimune Group
Price$4.60
Change-$0.13 (-2.75%)
Volume$100
Capitalization369.2M
KYMR vs REPL Comparison Chart in %
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. REPL commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a StrongBuy and REPL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (KYMR: $57.90 vs. REPL: $4.73)
Brand notoriety: KYMR and REPL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 79% vs. REPL: 28%
Market capitalization -- KYMR: $4.14B vs. REPL: $369.2M
KYMR [@Biotechnology] is valued at $4.14B. REPL’s [@Biotechnology] market capitalization is $369.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileREPL’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • REPL’s FA Score: 1 green, 4 red.
According to our system of comparison, both KYMR and REPL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 6 TA indicator(s) are bullish while REPL’s TA Score has 6 bullish TA indicator(s).

  • KYMR’s TA Score: 6 bullish, 4 bearish.
  • REPL’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, REPL is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +2.93% price change this week, while REPL (@Biotechnology) price change was +14.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.50%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +83.81%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 30, 2025.

REPL is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+5.50% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.14B) has a higher market cap than REPL($369M). KYMR YTD gains are higher at: 43.922 vs. REPL (-60.941). KYMR (-267.03M) and REPL (-268.18M) have comparable annual earnings (EBITDA) . KYMR has more cash in the bank: 665M vs. REPL (403M). REPL has less debt than KYMR: REPL (76.3M) vs KYMR (85.7M). KYMR has higher revenues than REPL: KYMR (44.7M) vs REPL (0).
KYMRREPLKYMR / REPL
Capitalization4.14B369M1,122%
EBITDA-267.03M-268.18M100%
Gain YTD43.922-60.941-72%
P/E RatioN/AN/A-
Revenue44.7M0-
Total Cash665M403M165%
Total Debt85.7M76.3M112%
FUNDAMENTALS RATINGS
REPL: Fundamental Ratings
REPL
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
14
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KYMRREPL
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
Bullish Trend 4 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
REPL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX47.330.27
+0.57%
Rydex Biotechnology C
CCCCX4.940.02
+0.41%
Center Coast Brookfield Midstream Foc C
JUEAX28.150.03
+0.11%
JPMorgan US Equity A
MALRX24.32N/A
N/A
BlackRock Advantage Large Cap Core Instl
VDSCX21.42-0.05
-0.23%
Victory Diversified Stock C